White Paper on Hepatocellular carcinoma Risk Stratification and Surveillance
We are excited to announce the release of our latest white paper, now available in the Journal of Hepatology. This paper delves into the crucial topic of hepatocellular carcinoma (HCC) risk stratification and surveillance, as presented at the recent ILCA Single Topic Workshop.
Our esteemed members have contributed their valuable insights and expertise, offering a unique perspective on how to shape the progress of liver cancer research and treatment.
Thank you for attending the “Single-Topic Workshop: HCC Risk Stratification and Surveillance” last 9-10 June, 2022 in Paris, France.
The Single Topic Workshop featured great sessions and lively debates from leading scientists and liver cancer specialists. We learned about the history of HCC surveillance research, novel biomarkers, potential alternative strategies to ultrasound, current challenges for HCC screening and type of cohort studies needed to define the high-risk population and validate biomarkers, and much more. Overall, this field looks very promising, but there’s still a lot of work and trials to be done.
Couldn’t attend? We have made the presentations available for ILCA members only courtesy of Fujifilm. Simply click on the button below and log in with your member credentials.
The Programme
Thursday 09 June 2022
TIME |
SESSION |
SPEAKER |
13:00 – 13:15 | Welcome & Introduction by the STW Co-chairs | Tim Meyer & Amit Singal |
13:15 – 13:40 | Risk stratification biomarkers – are we close? | Yujin Hoshida |
13:40 – 14:05 | Risk stratification after resection: Can we tailor surveillance for recurrence | Eric Vibert |
14:05 – 14:30 | HCC chemoprevention: Current options and the horizon | Neehar Parikh |
14:30- 15:00 | Panel Discussion | All |
15:00 – 15:20 | Coffee Break | |
15:20 – 15:45 | Biomarkers for HCC diagnosis | Josep M. Llovet |
15:45 – 16:10 | Biomarkers for HCC prognosis and treatment response | Tim Meyer |
16:10- 16:35 | Radiomics for HCC diagnosis and prognosis on day | Maxime Ronot |
16:35 – 17:05 | Panel Discussion | All |
Friday 10 June 2022
TIME |
SESSION |
SPEAKER |
08:30 – 08:50 | HCC surveillance – current recommendations and supporting evidence | Maria Reig |
08:50 – 09:10 | HCC surveillance utilization and potential interventions | Nicole Rich |
09:10 – 09:30 | Limitations of HCC surveillance test effectiveness and alternative imaging | Valerie Vilgrain |
09:30 – 09:50 | Precision screening for HCC: Is it possible and what do we need? | Pierre Nahon |
09:50 – 10:20 | Panel Discussion | All |
10:20 – 10:40 | Coffee Break | |
10:40 – 11:00 | Phases of biomarker validation | Jorge Marrero |
11:00 – 11:20 | Emerging serum biomarkers for early HCC detection | Amit Singal |
11:20 – 11:40 | cfDNA for early HCC detection | Augusto Villanueva |
11:40 – 12:10 | Panel Discussion | All |
12:10 – 13:30 | Lunch | |
13:30 – 13:50 | Patient advocacy perspective | Andrea Wilson |
13:50 – 14:05 | Bench to bedside: commercialization of biomarkers | Jeff Winick |
14:05 – 14:20 | Bench to bedside: commercialization of biomarkers | Marilyn Olson |
14:20 – 14:30 | Closing by the STW Co-chairs | Tim Meyer & Amit Singal |
Meet the Chairs
Dr. Amit Singal
STW Co-Chair / UT Southwestern Medical Center, USA
Dr. Tim Meyer
STW Co-Chair / UCL Cancer Institute, University College, UK
Meet the Speakers
The Venue
The workshop will take place in Holiday Inn Paris–Porte De Clichy Hotel
located in Paris’ north-western gateway district at the centre of “Grand Paris” project, an area where many international companies and future Judicial Precinct are located.
Partners & Supporters
ILCA warmly thanks all partners for their unrestricted support to the single-topic workshop and their commitment to help advance liver cancer science.
ILCA Industry Partners
If your organisation wishes to partner with ILCA and take part in the Single-Topic Workshop, please contact Jas Sidhu at [email protected] for sponsorship and exhibition opportunities. For media partnership, please contact Paulina Linares at [email protected].